module 6 inactivated poliovirus vaccine aefi monitoring training for inactivated poliovirus vaccine...
TRANSCRIPT
Module 6
Inactivated poliovirus vaccine AEFI monitoring
Training for Inactivated Poliovirus Vaccine (IPV) introduction
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
2 |
Learning objectivesLearning objectives
At the end of the module, the participants will be able to:– Identify adverse events following immunization
(AEFIs)– Explain how to report AEFIs
Duration– 30 minutes
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
3 |
What is an AEFI ?11
Which AEFIs do I report?
33
Key issues
How do I report an AEFI ?
44
How likely is an AEFI after IPV ?
22
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
4 |
Adverse Event Following Immunization (AEFI)
Adverse Event Following Immunization (AEFI)
What is an AEFI?– A medical incident– Takes place after an immunization– Causes concern– Is believed to be caused by immunization
How are AEFIs categorized? Type Severity
- Vaccine reaction- Programme error- Coincidental- Injection reaction- Unknown
- Minor- Severe
• Serious• Non-serious
… these are defined soon
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
5 |
Programme errorsProgramme errors
Errors in vaccine preparation, handling, storage, or administration
Preventable
Often constitute the greatest proportion of AEFIs
Identification and correction are of great importance
Examples: – Non-sterile injection– Injection at incorrect site– Administration of frozen vaccine
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
6 |
Coincidental eventsCoincidental events
Occur after vaccination, but not caused by the vaccine or its administration
Occur during infancy when illnesses are common and congenital or early neurological conditions become apparent
Onset temporally associated with vaccination, and inevitable when vaccinating these age groups
Applying normal incidence of disease and death in these age groups along with coverage allows estimation of expected numbers of coincidental events after immunization
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
7 |
Injection reactionsInjection reactions
Immunization anxiety-related reactions in anticipation to and as a result of an injection of any kind
Not related to the vaccine but to fear of the injection
You may encounter 4 types of injection reactions :– Fainting
– Hyperventilation
– Vomiting
– Convulsions
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
8 |
Vaccine reactions can be classified into two levels of severity
Vaccine reactions can be classified into two levels of severity
Minor reactions
– Usually occur within few hours
– Resolve quickly– Pose little danger– Local: pain, swelling,
redness at injection site – Systemic: fever,
malaise, muscle pain, headache, or loss of appetite
Severe reactions- require timely and appropriate management– Usually do not result in
long-term problems– Can be disabling– Are rarely life threatening– Include seizures and
allergic reactions caused by body’s reaction to a particular component in a vaccine
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
9 |
Some severe events can be SERIOUS
Some severe events can be SERIOUS
A serious AEFI- Any untoward medical occurrence that at any dose:– Results in death– Is life threatening– Requires in-patient hospitalization or
prolongation of existing hospitalization– Results in persistent or significant
disability or incapacity
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
10 |
The difference between serious and severe adverse events
The difference between serious and severe adverse events
A severe reaction is a broader term which includes SERIOUS reactions + reactions that do not necessarily lead to long term problems.
Severe reactions must be reported
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
11 |
How likely is an AEFI after IPV?How likely is an AEFI after IPV?
IPV is a very safe vaccineNot associated with serious systemic
AEFIsInactivated vaccine – therefore, no risk of
vaccine-associate polioCan safely be administered with other recommended childhood vaccines, including OPV and other injectable vaccines
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
12 |
Which AEFIs should be reported?Which AEFIs should be reported?
Any severe events or AEFI that is of concern to the parents or health care worker
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
13 |
Report the event through existing AEFI reporting systems established by national immunization programs
National authorities
Community, district, and regional levels
Signs or symptoms
believed to be related to the
vaccine
Where to report AEFI's Where to report AEFI's
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
14 |
Conducting an AEFI investigationConducting an AEFI investigation
Some AEFI reports will need further investigation by the immunization programme managers
Components of AEFI investigation:– Identify specifications of implicated vaccine– Examine operational aspects of the programme which may
have led to immunization errors– Search for other potential AEFI cases/clustering– Compare background risk to reported rate of AEFI– Confirm (or propose) the diagnosis and determine
outcome– In collaboration with experts, determine if AEFI was
vaccine-related
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
15 |
What information should an AEFI report contain?
What information should an AEFI report contain?
Client informationDetails about the vaccine
– Type– Date– Manufacturer– Lot/expiration date– Site/route of immunization,
etc.
Description of adverse event(s) and any associated events
Medical and treatment history
Reporter details
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
16 |
Communication with caretakers in case of an AEFI
Communication with caretakers in case of an AEFI
Reassure the caretaker
Admit uncertainty
Convey that the AEFI will be reported and investigated fully
Keep the community informed with follow-up information
Inactivated poliovirus vaccine AEFI monitoring, Module 6 I 19 April 2023
17 |
Key messagesKey messages
AEFIs can be minor or severe (which include serious events)
AEFIs should be reported through existing AEFI reporting systems/forms
The safety profile of IPV is excellentMost infants who get IPV do not experience any
side effects In case of an AEFI
– Reassure the caretaker– Admit uncertainty– Investigate fully– Keep the community informed